Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy
Clinical trial NCT02412462 · COMPLETED
Trial details
- NCT number
- NCT02412462
- Sponsor
- Alethia Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2017-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.